Find clinical trials for COVID-19 in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Communicable Diseases
Coronavirus Infections
Human Influenza
Post-Acute COVID-19 Syndrome
Respiratory Distress Syndrome

COVID-19 trials near Taipei City, TWN:

The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine

BNT162b2 and mRNA 1273 in clinical trials. The emergence of highly transmissible and mutant variants of SARS-COV-2 has raised the concern of COVID...

Active, not recruiting
Breakthrough Infection
Biological: BNT162b2
Biological: mRNA-1273

Phase 1, Phase 2

Chang Gung Medical Foundation
Chang Gung Medical Foundation

Taoyuan city, Taiwan

To evaluate whether probiotics PS23 can improve the symptoms of patients with long COVID-19 ; also to evaluate the effects on blood...

Post-COVID-19 Syndrome
Dietary Supplement: PS23 heat-treated
Mackay Memorial Hospital

Taipei, Taiwan

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
Biological: AZD3152 (Sub-study)
Biological: Placebo (Parent study Sentinel Safety Cohort)

Phase 2, Phase 3


Taipei, Taiwan and 214 other locations

the immunogenicity by the antigen-specific immunoglobulin as well as the potential efficacy of study intervention in preventing COVID-19...

COVID-19 Vaccine
Biological: MVC-COV1901(6 Months)
Biological: MVC-COV1901(3 Months)

Phase 4

Taoyuan General Hospital

Taoyuan, Taiwan

Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of SNS812 in Participants with Mild to Moderate COVID...

Active, not recruiting
Mild to Moderate COVID-19
Drug: Placebo

Phase 2

Oneness Biotech

Taipei, Taiwan and 4 other locations

This is a Phase II, multi-center, double-blind, randomized, interventional study in approximately 120 subjects to evaluate clinical benefit of CX-494...

Not yet enrolling
Influenza With Pneumonia
SARS-CoV-2 -Associated Pneumonia
Drug: CX-4945 (Influenza virus domain)
Drug: CX-4945 (SARS-CoV-2 domain)

Phase 2

Senhwa Biosciences

Taipei, Taiwan

The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...

Viral Lung Infection and Acute Respiratory Failure
Drug: Placebo
Drug: Tozorakimab

Phase 3


Taipei, Taiwan and 380 other locations

treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and ...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: placebo for risankizumab
Drug: risankizumab

Phase 3


Taipei City, Taiwan and 425 other locations

in Study M16-006 or Study M15-991 with no final endoscopy due to the Covid-19 pandemic. Additional objectives are to further invest...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

Phase 3


Taipei City, Taipei, Taiwan and 496 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems